Clinical Trial: A Study to Assess the Pharmacokinetics, Safety and Tolerability of Single-dose Adagrasib (BMS-986503) in Healthy Participants of Japanese Descent

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07723118) titled 'A Study to Assess the Pharmacokinetics, Safety and Tolerability of Single-dose Adagrasib (BMS-986503) in Healthy Participants of Japanese Descent' on July 20.

Brief Summary: The aim of this study is to assess the pharmacokinetics, safety and tolerability of single-dose Adagrasib (BMS-986503) in healthy participants of Japanese descent

Study Start Date: Aug. 05

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Adagrasib

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Mirati Therapeutics Inc.

Published by HT Digital Content Services with permission from Health Dai...